Clinical Trial Update: Pharmacokinetic (PK) Evaluation of Nalmefene Formulations [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic evaluation examines nalmefene formulations for opioid overdose. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Overdose

Drugs mentioned

• Nalmefene (nalmefene)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Opioid Overdose | Phase 1 | Status: COMPLETED